These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 12820338

  • 1. Her2/neu analysis in formalin-fixed, paraffin-embedded breast carcinomas: comparison of immunohistochemistry and multiparameter DNA flow cytometry.
    Leers MP, Hoop JG, Nap M.
    Anticancer Res; 2003; 23(2A):999-1006. PubMed ID: 12820338
    [Abstract] [Full Text] [Related]

  • 2. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
    Leers MP, Hoop JG, van Beers M, van Rodijnen N, Pannebakker M, Nap M.
    Cytometry B Clin Cytom; 2005 Mar; 64(1):43-52. PubMed ID: 15668953
    [Abstract] [Full Text] [Related]

  • 3. Comparison of flow and image cytometry for DNA content analysis of fresh and formalin-fixed, paraffin-embedded tissue in breast carcinoma.
    Chen TL, Luo I, Mikhail N, Rasková J, Raska K.
    Cytometry; 1995 Sep 15; 22(3):181-9. PubMed ID: 8556949
    [Abstract] [Full Text] [Related]

  • 4. Simultaneous detection of HER2/neu gene amplification and protein overexpression in paraffin-embedded breast cancer.
    Lottner C, Schwarz S, Diermeier S, Hartmann A, Knuechel R, Hofstaedter F, Brockhoff G.
    J Pathol; 2005 Apr 15; 205(5):577-84. PubMed ID: 15732132
    [Abstract] [Full Text] [Related]

  • 5. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
    Martínez-Arribas F, Núñez MJ, Piqueras V, Lucas AR, Sánchez J, Tejerina A, Schneider J.
    Anticancer Res; 2002 Apr 15; 22(1A):295-8. PubMed ID: 12017306
    [Abstract] [Full Text] [Related]

  • 6. Expression of HER2 and the coamplified genes GRB7 and MLN64 in human breast cancer: quantitative real-time reverse transcription-PCR as a diagnostic alternative to immunohistochemistry and fluorescence in situ hybridization.
    Vinatzer U, Dampier B, Streubel B, Pacher M, Seewald MJ, Stratowa C, Kaserer K, Schreiber M.
    Clin Cancer Res; 2005 Dec 01; 11(23):8348-57. PubMed ID: 16322295
    [Abstract] [Full Text] [Related]

  • 7. [Her-2/neu, Ki-67 expression and ploidy in breast carcinoma].
    Lukashina MI, Glukhova EI, Zhukova LG, Ermilova VD, Bogatyrev VN, Baryshnikov AIu.
    Arkh Patol; 2003 Dec 01; 65(5):25-9. PubMed ID: 14664144
    [Abstract] [Full Text] [Related]

  • 8. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL.
    APMIS Suppl; 2003 Dec 01; (108):1-67. PubMed ID: 12874968
    [Abstract] [Full Text] [Related]

  • 9. Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer.
    Baak JP, Chin D, van Diest PJ, Ortiz R, Matze-Cok P, Bacus SS.
    Lab Invest; 1991 Feb 01; 64(2):215-23. PubMed ID: 1671789
    [Abstract] [Full Text] [Related]

  • 10. A technique for automatic/interactive assessment of the proliferating fraction of neoplastic cells in solid tumors. A methodological study on the Ki-67 immunoreactive cells in human mammary carcinomas, including a comparison with the results of conventional S-phase fraction assessments by means of DNA cytometry.
    Parrado C, Falkmer UG, Höög A, Falkmer S, Ahrens O, Rius F, Grimelius L.
    Gen Diagn Pathol; 1996 Mar 01; 141(3-4):215-27. PubMed ID: 8705786
    [Abstract] [Full Text] [Related]

  • 11. HER2 status in breast cancer determined by IHC and FISH: comparison of the results.
    Mrozkowiak A, Olszewski WP, Piaścik A, Olszewski WT.
    Pol J Pathol; 2004 Mar 01; 55(4):165-71. PubMed ID: 15757204
    [Abstract] [Full Text] [Related]

  • 12. DNA ploidy, proliferation, and neu-oncogene protein overexpression in breast carcinoma.
    Lee AK, Wiley B, Loda M, Bosari S, Dugan JM, Hamilton W, Heatley GJ, Cook L, Silverman ML.
    Mod Pathol; 1992 Jan 01; 5(1):61-7. PubMed ID: 1347424
    [Abstract] [Full Text] [Related]

  • 13. Comparison of immunohistochemistry by automated cellular imaging system (ACIS) versus fluorescence in-situ hybridization in the evaluation of HER-2/neu expression in primary breast carcinoma.
    Tawfik OW, Kimler BF, Davis M, Donahue JK, Persons DL, Fan F, Hagemeister S, Thomas P, Connor C, Jewell W, Fabian CJ.
    Histopathology; 2006 Feb 01; 48(3):258-67. PubMed ID: 16430472
    [Abstract] [Full Text] [Related]

  • 14. Expression of HER2/neu in primary and metastatic breast cancer.
    Tuziak T, Olszewski WP, Olszewski W, Pieńkowski T.
    Pol J Pathol; 2001 Feb 01; 52(1-2):21-6. PubMed ID: 11505677
    [Abstract] [Full Text] [Related]

  • 15. Multiparameter flow cytometry as a tool for the detection of micrometastatic tumour cells in the sentinel lymph node procedure of patients with breast cancer.
    Leers MP, Schoffelen RH, Hoop JG, Theunissen PH, Oosterhuis JW, vd Bijl H, Rahmy A, Tan W, Nap M.
    J Clin Pathol; 2002 May 01; 55(5):359-66. PubMed ID: 11986342
    [Abstract] [Full Text] [Related]

  • 16. HER2/neu expression and gene alterations in pancreatic ductal adenocarcinoma: a comparative immunohistochemistry and chromogenic in situ hybridization study based on tissue microarrays and computerized image analysis.
    Tsiambas E, Karameris A, Dervenis C, Lazaris AC, Giannakou N, Gerontopoulos K, Patsouris E.
    JOP; 2006 May 09; 7(3):283-94. PubMed ID: 16685109
    [Abstract] [Full Text] [Related]

  • 17. Histological tumor grade correlates with HER2/c-erB-2 status in invasive breast cancer: a comparative analysis between immunohistochemical (CB11 clone and Herceptest), FISH and differential PCR procedures.
    López-Guerrero JA, Navarro S, Noguera R, Almenar S, Pellin A, Vázquez C, Llombart-Bosch A.
    Arkh Patol; 2003 May 09; 65(1):50-5. PubMed ID: 12669615
    [Abstract] [Full Text] [Related]

  • 18. Study of HER2/neu status in Qatari women with breast carcinoma.
    Rasul KI, Mohammaed K, Abdalla AS, Chong-Lopez A, Ahmad MA, Al-Homsi MU, Al-Hassan AM, Al-Alosi AS, Bener A.
    Saudi Med J; 2003 Aug 09; 24(8):832-6. PubMed ID: 12939666
    [Abstract] [Full Text] [Related]

  • 19. Influence of neoadjuvant chemotherapy on HER2/neu status in invasive breast cancer.
    Li P, Liu T, Wang Y, Shao S, Zhang W, Lv Y, Yi J, Wang Z.
    Clin Breast Cancer; 2013 Feb 09; 13(1):53-60. PubMed ID: 23103368
    [Abstract] [Full Text] [Related]

  • 20. Multiparameter analysis of DNA content and cytokeratin expression in breast carcinoma by laser scanning cytometry.
    Clatch RJ, Walloch JL, Foreman JR, Kamentsky LA.
    Arch Pathol Lab Med; 1997 Jun 09; 121(6):585-92. PubMed ID: 9199623
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.